Table 2 rATG indication and treatment characteristics
Pre (n = 124) | Post (n = 353) | P value | |
|---|---|---|---|
Indication for rATG | <0.001 | ||
High risk recipient and donor | 3 (2.4%) | 28 (7.9%) | |
High risk recipient | 66 (53.2%) | 112 (31.7%) | |
High risk donor | 16 (12.9%) | 71 (20.1%) | |
Low risk recipient and donor | 39 (31.5%) | 142 (40.2%) | |
Mean total dose rATG (mg) | 467.7 ± 157.5a | 379.5 ± 160.0 | <0.0001 |
Mean total weight-adjusted dose rATG (mg/kg) | 6.0 ± 1.4 | 5.1 ± 2.0 | <0.0001 |
Median number rATG dosesb | 5 (4, 6) | 5 (4, 6) | 0.17 |